metabolic profiling of Parkinson's disease and mild cognitive impairment

Background: Early diagnosis of Parkinson's disease and mild cognitive impairment is important to enable prompt treatment and improve patient welfare, yet no standard diagnostic test is available. Metabolomics is a powerful tool used to elucidate disease mechanisms and identify potential biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Burté, Florence, Houghton, David, Lowes, Hannah, Pyle, Angela, Nesbitt, Sarah, Yarnall, Alison, Yu‐Wai‐Man, Patrick, Burn, David J., Santibanez‐Koref, Mauro, Hudson, Gavin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485028/
https://www.ncbi.nlm.nih.gov/pubmed/28394042
http://dx.doi.org/10.1002/mds.26992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485028/
https://www.ncbi.nlm.nih.gov/pubmed/28394042
http://dx.doi.org/10.1002/mds.26992

Ejemplares similares